JTC2017
the neurotransmitter ( inhibits 3. Storage (membrane bound preformed
transmission of the action vesicles)
potential) 4. Metabolism
5. Release (especially Ca channel inhibitors)
SITES OF DRUG ACTION 6. Uptake ( either back to the nerve ending or it
goes to the glial cells for recycling)
Most CNS drugs act directly on synapses 7. Degradation
Can activate or block pre and post synaptic receptors 8. Receptor for the transmitter
for specific transmitters 9. Receptor induced increase or decrease in
These drugs may interfere with the action of ionic conductance
secondary messengers ( These drugs target 10. Retrograde signaling
metabotropic receptors) o The post synaptic neuron signals the
Some drugs act upon directly on the molecular presynaptic that the neurotransmitter
components of ion channels on axons in the receptor is already in excess
If ion channels are inhibited = no conductance = no resulting to the liberation of a
action potential diffusible messenger from the
~ Ex.1 Carbamazepine and Phenytoin stabilizes the postsynaptic terminal that travels
membrane potential thus preventing seizure across the synaptic cleft and
~ Ex.2 General Anesthesia blocks the entry of ions activates the receptors in the
in ion channels therefore there is no action potential presynaptic terminal resulting to the
and sensation cannot be felt on the site of alteration(decrease) in synaptic
application. transmitter release so as to avoid
* (Examples 1 and 2 exert their effect through direct resistance
interactions with the molecular components of the
ion channel on axons) CELLULAR ORGANIZATION OF THE BRAIN
~ Ex.3 Parachlorophenylalanine inhibits serotonin I. Hierarchical systems
synthesis
Include all the pathways involved in SENSORY
~ Ex.4 Reserpine inhibits storage of
PERCEPTION and MOTOR CONTROL
catecholamines/monoamines ( stabilizes vesicles of
cathecolamines ) Motor Neurons
~ Ex.5 Amphetamine induces release of 1. Upper
cathecolamines ( p. 360 and chapters 6,9,&32 ) o Pre central gyrus
~ Ex.6 Capsaicin causes the release of substance P 2. Lower
from sensory neurons o Ventral horn
~ Ex.7 Tetanus toxin blocks the release of Sensory Neurons
transmitters 1. Upper
~ Ex.8 Anticholinesterase blocks the degradation of o Post central gyrus
Cathecolamines (Ach) 2. Lower
o Dorsal root ganglion --- Dorsal horn
CNS drugs also act on synthesis, storage, release, Pathways are/have :
metabolism and reuptake of neurotransmitters such o Traced/ delineated
as SSRI or selective-serotonin reuptake inhibitors o Large MYELINATED fibers
Selectivity of CNS drug action o Occurs in bursts of action potential
1. In most cases, different neurotransmitters Hierarchical pathway neuron types
are released by different groups of neurons 1. Relay or Projection Neurons
Segregated into neuronal o Large soma
systems that correspond to o Long distance transmission
different CNS functions o Synapses to local inter-neurons
2. There is a multiplicity of response for each o Excitatory
neurotransmitter
o Involves ionotropic receptors (short
Steps wherein which drugs can alter synaptic
duration)
transmission ( refer to p 360 ; figure 21-4 of o Releases glutamate and aspartate
Katzungs )
2. Local Circuit Neurons
1. Action potential in presynaptic fiber
o Smaller soma
2. Synthesis of transmitter
JTC2017
o Axons spread in a tree like manner o Ex. Norepinephrine : Locus caeruleus *
(arborize) in the immediate vicinity of a ( in the caudal pontine)
cell body o Long lasting synaptic effects
o Conveys information on vast areas of
the CNS as it must be affected
simultaneously and uniformly
o Inhibitory
o Releases GABA and glycine
(interneurons)
Types of hierarchical pathways ( refer to figure o SLEEP,WAKING,ATTENTION,
21-5 p. 361 of Katzungs) APPETITE, EMOTIONS
1. Feed-forward and Feed-back (recurrent)
pathways CENTRAL NEUROTRANSMITTERS
o Feed-forward pathways
Criteria for transmitter identification
One direction
1. Localization: A suspected transmitter must
From input to output
be located in the PRESYNAPTIC terminal
One neuron at a time of interest
o Feed-back pathways 2. A suspected neurotransmitter must be
The output of the neuron is released from the presynaptic terminal in
added to the next input and fed response to neuronal activity and increase in
back to the same neuron presynaptic Ca concentration/conductance
Can receive a sequence of 3. Application of a candidate substance should
values as input and release a produce a response that mimics the action of
sequence of values as output the actual neurotransmitter released
2. Axoaxonic interaction 4. Application of a selective antagonist should
o Axon of an inhibitory neuron acts upon block the response of applying a candidate
the presynaptic axon terminal fiber thus substance
inhibiting the release of ~ There should be predictability ( 3 &4 )
neurotransmitters o To produce the same sort of
o Found in terminals of sensory axons postsynaptic response that is seen with
o Presynaptic inhibition physiologic activation of the synapse
II. Nonspecific or diffused neuronal systems (ie, must exhibit synaptic mimicry)
o Contains neurotransmitters like Ach and Amino Acid Neurotransmitters
monoamines 1. Glutamate
o Varicosities ; broadly distributed o Excitatory
o Differs from hierarchical system o For learning and memory ( NMDA )
o Cell bodies with small nuclei in the o Released by Ca dependent exocytosis
brainstem produce neurotransmitters of o Cleared by glutamate transporters found
this system ( Ex. Raphe nuclei : 5-HT, in the glial cells
serotonin ) o In the glia
o Neurons diffuse throughout the brain Glutamate ---------> Glutamine
and spinal cord via glutamine synthetase
o Unmyelinated = slow conduction o When taken back to the presynaptic
o Innervates several functionally different terminal
parts of the CNS Glutamine ---------> Glutamate
o Synapses to modulating neurons within via enzyme glutaminase
the hierarchical system o Vesicular glutamate transporter
o Neuronal systems in the neocortex (VGLUT)
Have tangential(diverging) Achieves high concentration of
organization = influences large glutamate in synaptic vesicles
areas in the cortex
o Most neurotransmitters that are under o Ionotropic glutamate receptors
the neuronal systems act predominantly i. AMPA
on metabotropic receptors a. Heterotetramers
JTC2017
b. GluA1-GluA4 e. Requires the
c. Permeable to binding of both
Na and K Glycine and
Glutamate
( contain GluA2 f. NMDA pore is
subunits) usually blocked
d. Only permeable by Mg
to Ca when g. Mg is removed
lacking GluA2 by strong
subunits depolarization
(present on thus opening
inhibitory inter- the NMDA
neurons) channel
e. Uniformly h. For the NMDA
distributed receptor
f. Receptor channel to
activation open: 1.
results in Glutamate must
channel bind to the
opening at receptor
RMP 2. Membrane
ii. KA should be
a. GluK1-GluK5 depolarized
b. GluK4 and i. Increase in
GluK5 are Intracellular
unable to form Ca
their own concentration
channels + channel
c. Usually opening =
permeable to Long-term
Na and K potentiation
d. Receptor (LTP) or
activation increase in
results in synaptic
strength
channel
opening at o Metabotropic glutamate receptors
RMP G protein coupled
Act indirectly on ion
iii. NMDA
a. Widely channels
distributed mGluR1-mGluR8
along the CNS Divided to 3 groups
b. Highly i. Group 1
permeable to Postsynapti
Ca , K, Na -cally
c. NMDA located
receptors Decreases
require GluN1 K
subunits
d. May contain 1 conductanc-
or 2 GluN2 e
subunits Activate
( GluN2A- PLC which
GluN2D) leads to IP3
JTC2017
mediated Increase Cl
Ca release (extracellular)condu
Excitatory -ctance
ii. Groups 2 and 3 Fast component
Presynaptic Ionotropic receptors
ally located Pentameric
Inhibitory
receptors
Activation
causes Ca
GABAb
channel
Presynaptically
inhibition
inhibit Ca
and
conductance
transmitter
Postsynaptically
release
induce K
inhibition
conductance
Only
Metabotropic
activated
receptors
when Slow component
glutamate Long lasting
concentrati Inhibit adenyl
on is too cyclase thus
high decreasing cAMP
Activation
generation
of these
receptors ACETYLCHOLINE (ACH)
inhibits
adenyl CNS responses are mediated by large G protein
cyclase and coupled muscarinic receptors for the muscarinic
decreases type
cAMP Cholenergic receptors
generation o M1 receptors
2. GABA and Glycine 1. Slow excitation
o Inhibitory 2. Produced by decreasing
o GABA is the primary membrane permeability to K
neurotransmitter in mediating IPSP 3. Activate PLC which leads to
o Released from local interneurons IP3 mediated Ca release
o GABA releasing neurons 4. More widespread muscarinic
All over CNS ( inc spinal action
o M2 receptors
cord)
o Glycine releasing neurons 1. Slow inhibition
2. Opens K channels
Abundant in the spinal cord
3. Inhibit adenyl cyclase thus
and brain stem
decreasing cAMP generation
o Glycine receptors
Cognitive functions
Pentameric
Renshaw cells ( Postsynaptic parasympathetic
B- alanine
Selectively permeable to Cl neurons)
o Nicotinic ; ionotropic = ( cation
Blocked by strychnine
o GABA receptors conductance)
GABAa Characterized with diffuse projections
JTC2017
Include neurons in Neostriatum, Medial septal Found on locus
nucleus and reticular formation caeruleus area
Pathway Presynaptic
1. Ch5-Ch8 ( cholinergic -Decreases Ca
brainstem nuclei) conductance
2. Medial septal nucleus (MSN) , Postsynapic-
Diagonal band of Broca (DB), Increases K
Nucleus Basalis of Meynert permeability
and decreases
MONOAMINE NEUROTRANSMITTERS cAMP
1. Dopamine B1
o Pathway Excitatory
Substantia Nigra--- Decrease K
Neostriatum conductance
Ventral Tegmental Area Increases
(VTA) ---nucleus cAMP
accumbens---limbic formation
cortex B2
o Regulates pituitary functions Inhibitory
o Metabotropic receptors Increase in
D1 like ( D1 and D5)
cAMP
D2 like ( D2,3,4) Increase in
o Slow inhibitory
electrogenic Na
o G protein Coupled
pump
o D1 receptor activation
o Most regions Norepinephrine
Increase cAMP
enhances excitatory inputs
formation
Direct
o D2 receptor activation
Blockade of K
( same as GABAb)
Presynaptic conductance
Decreases Ca Indirect mechanisms
Involves
conductance
Postsynaptic inhibition of
Increases K inhibitory local
conductance circuit neurons
Decreases o Attention and arousal
cAMP
3. Serotonin (5-HT)
formation o Pathway originates from
2. Norepinephrine
Raphe nuclei
o Pathway
o Contained by unmyelinated
Locus caeruleus/lateral
fibers
tegmental area
o Metabotropic except for 5-HT3
o Metabotropic receptors
A1 (ionotropic)
o 5-HT3 exerts rapid excitatory
Excitatory
Decrease K action
Increase o On most sites 5-HT exerts
DAG,IP3 inhibitory actions
o Regulation of all brain functions
A2 ( hyperpolarization)
Inhibitory
JTC2017
o 5-HT1a o Substance-P = slow excitatory role
Inhibitory o Transfer noxious stimuli
Increase K conductance o Tachykinins
Decrease cAMP o Excitatory : decrease K conductance ; increase
formation DAG ,IP3
o 5-HT2a
Excitatory OPOIDS
Increase IP3,DAG
Decrease K o Inhibitory
o Metabotropic
conductance
o Inhibits adenyl cyclase- decrease in cAMP
o 5-HT3
Excitatory formation
Increase cation o Mu = Endorphin= Presynaptic
o Delta= Enkephalin=Postsynaptic
conductance
o Kappa = Dynorphin =Postsynaptic
o 5-HT4
Excitatory OREXIN
Decrease K
conductance o Peptide neurotransmitters
4. Histamine o Also known as Hypocretins
o Made by Tuberomammillary o Released from large, dense core vesicles
nucleus (TMN) located in the o Metabotropic
ventral posterior hypothalamus o OX1- Excitatory
o Throughout the CNS o OX2- Excitatory
o Arousal , attention, feeding o Co-releases glutamate
behavior, memory o Associated with wakefulness, energy
o H1-H4 homeostasis, reward
o Metabotropic receptors o Activate monoamine and Ach molecules
H1
Excitatory ENDOCANNABINOIDS
Decrease K
o Primary psychoactive ingredient in cannabis
conductance
Increase DAG o Retrograde synaptic messengers ( released from
and IP3 postsynaptic terminal and travels back to the
H2 presynaptic terminal, activating CB1 receptors
Excitatory to suppress the release of the neurotransmitter)
Decrease K o Activates widely distributed cannabinoid
conductance receptor
Increase cAMP CB1
formation Primarily located on presynaptic
H3 terminals
Inhibitory Inhibitory- presynaptic = Ca
autoreceptors conductance decreases; cAMP
production decreases
NEUROPEPTIDES Ligands include
Anandamide
o Found in the periphery 2-AG
o Act as neurotransmitters o Rapidly
o Packaged in large dense core vesicles synthesized
o Release is independently regulated o Response to
o Most are metabotropic
depolarization
o Serve modulator roles
JTC2017
NITRIC OXIDE 6) K : Postsynaptic
7) IP3 and DAG never decreases
o Nitric oxide synthase ( NOS ) is activated by 8) cAMP production only increases when
calcium-calmodulin excitatory
o Nitric oxide is generated by the activation of 9) K and cAMP lagi magkasama sa
NMDA which increases the conductance of Ca inhibitory
o Retrograde messenger 10) K and IP3,DAG lagi magkasama sa
o Known for long term depression of synaptic excitatory
transmission in the cerebellum 11) 5-HT1A receptors and GABAb
o Released by the endothelium as a vasodilator receptors share the same K channel.
12) Decrease in K : increase in IP3,DAG
PURINES ~Ach M1= 5-HT2a= Norepinephrine
A1= Histamine H1=Tachykinins
o Receptors include NK1,2,3
Adenosine 13) Increase in K: decrease in cAMP
Acts on metabotropic adenosine ~Ach M2 = 5-HT1a = Opoids
1 /A1 receptors kappa=Opoids delta
Presynaptic A1 receptors 14) Inhibitory post and presynaptic
inhibit calcium channels thus ~Dopamine D2=GABAb=
inhibit the release of Norepinephrine A2
neurotransmitters 15) Excitatory increase in cation
ATP conductance
Released from catecholinergic ~Ach Nicotinic=
synaptic vesicles NMDA(Ca)=AMPA=KA=5-HT3
Converted to adenosine 16) Inhibitory Cl conductance
extracellularly by nucleotidases ~ GABAa= Glycine B-alanine
P2X family 17) Decrease in Ca : Decrease in cAMP
Nonselective ligand- ~ Glutamate metabotropic(excitatory
gated cation channels post synaptic) = Opoid Mu =
Ionotropic Endocannabinoids CB1
P2Y family 18) Decrease in K : Increase cAMP
Metabotropic ~ Norepinephrine B1= Histamine H2
UTP 19) Special
UDP a. DOPAMINE- D1:increase
o Play a role in neuropsychiatric disorders cAMP: inhibitory
o Memory, wakefulness and appetite b. SEROTONIN- 5-HT4: decrease
K conductance: excitatory
PATTERNS AND TRENDS c. HISTAMINE- H3=Inhibitory
**Refer to Table 21-2 p.364-365 for a more auto receptors
complete summary d. OREXINS-
1) cAMP and K are indirectly proportional OX1:OX2:Glutamate co
2) (IP3, DAG) and K are indirectly release: excitatory
proportional e. NOREPINEPHRINE increase
3) Ca and cAMP are directly proportional in sodium pump ; increase Ca
4) IP3 and DAG are requirements to
produce Ca hence (IP3,DAG) and Ca
are directly proportional
5) Ca : Presynaptic
JTC2017